10 completed. 10 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Completed 10 |
| Phase 2 | 2 | Completed 2 |
Follow Impaired Glucose Tolerance: new trials by email Literature Review of Impaired Glucose Tolerance trials Research Report on Impaired Glucose Tolerance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose Tolerance Subetta, Placebo - Impaired Glucose Tolerance | Phase 3 | Completed | Materia Medica Holding | 538 | 2018-10-10 | 2021-02-04 |
| Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM) Metformin XR plus placebo, Metformin XR plus liraglutide - Gestational Diabetes Mellitus, Type 2 Diabetes Mellitus | Phase 3 | Completed | Woman's | 153 | 2011-08-11 | 2019-07-26 |
| Enhancing Fitness in Older Pre-diabetic Veterans Physical Activity Counseling - Impaired Glucose Tolerance, Obesity | Phase 2 / Phase 3 | Completed | US Department of Veterans Affairs | 302 | 2008-10-01 | 2015-04-27 |
| Vitamin D for the Prevention of Diabetes Type 2 cholecalciferol, Placebo - Impaired Glucose Tolerance | Phase 2 / Phase 3 | Completed | University of Tromso | 511 | 2008-03-01 | 2015-09-22 |
| Prevention of Type 2 Diabetes Mellitus by L-Arginine in Patients With Metabolic Syndrome L-arginine, Placebo - Metabolic Syndrome, Impaired Glucose Tolerance | Phase 3 | Completed | IRCCS San Raffaele | 142 | 2005-12-01 | 2009-06-10 |
| A Lifestyle and Combination Medication Therapy Diabetes Prevention Study Avandamet [Rosiglitazone 2mg/Metformin 500mg] BID - Impaired Glucose Tolerance, Diabetes | Phase 3 | Completed | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | 207 | 2004-06-01 | 2012-05-24 |
| Actos Now for Prevention of Diabetes (ACT NOW) Pioglitazone, Placebo - Impaired Glucose Tolerance, Type 2 Diabetes | Phase 3 | Completed | The University of Texas Health Science Center at San Antonio | 602 | 2004-01-01 | 2016-08-11 |
| To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients Rosiglitazone, Ramipril - Diabetes, Impaired Glucose Tolerance | Phase 3 | Completed | Universiti Sains Malaysia | 66 | 2002-10-01 | 2009-07-16 |
| The Study of Atherosclerosis With Ramipril and Rosiglitazone Ramipril, Rosiglitazone - Atherosclerosis, Impaired Glucose Tolerance | Phase 3 | Completed | Gerstein, Hertzel, MD | 1200 | 2001-07-01 | 2008-08-25 |
| The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial Ramipril, Rosiglitazone - Impaired Glucose Tolerance, Cardiovascular Disease | Phase 3 | Completed | Gerstein, Hertzel, MD | 5000 | 2001-07-01 | 2009-11-10 |
Glucose Intolerance (10) · Diabetes Mellitus (4) · Diabetes Mellitus, Type 2 (3) · Cardiovascular Diseases (2) · Metabolic Syndrome (2) · Atherosclerosis (1) · Diabetes, Gestational (1) · Glucose Metabolism Disorders (1) · Insulin Resistance (1) · Motor Activity (1) · Obesity (1)
Hyperglycemia (10) · Metabolic Diseases (10) · Nutritional and Metabolic Diseases (10) · Glucose Metabolism Disorders (9) · Endocrine System Diseases (7) · Diabetes Mellitus (3) · Hyperinsulinism (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Behavior (1) · Body Weight (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Insulin Resistance (1) · Nutrition Disorders (1) · Overnutrition (1)
Rosiglitazone (4) · Ramipril (3) · Arginine (1) · BID protein, human (1) · Cholecalciferol (1) · Liraglutide (1) · Pioglitazone (1) · Vitamin D (1) · rosiglitazone-metformin combination (1) · subetta (1)
Gerstein, Hertzel, MD (2) · IRCCS San Raffaele (1) · Materia Medica Holding (1) · Samuel Lunenfeld Research Institute, Mount Sinai Hospital (1) · The University of Texas Health Science Center at San Antonio (1) · US Department of Veterans Affairs (1) · Universiti Sains Malaysia (1) · University of Tromso (1) · Woman's (1)
United States (3) · Canada (1) · Italy (1) · Malaysia (1) · Norway (1) · Russia (1)
Abdul Rashid A Rahman, MRCP, PhD (1) · Bernard Zinman, MD (1) · Eva Lonn, MD (1) · Hertzel Gerstein, MD (1) · Karen E Elkind-Hirsch, Ph.D. (1) · Miriam C. Morey, PhD (1) · PierMarco Piatti, MD (1) · Ralph A. DeFronzo, M.D. (1) · Renee Harris, M.D. (1) · Rolf Jorde, Professor (1) · Salim Yusuf, MD (1) · Stewart Harris, MD (1)
PMID 16980380, PMID 16997664, PMID 18268075, PMID 19477351, PMID 19640291, PMID 21428766, PMID 21515846, PMID 22059803, PMID 22291490, PMID 22866170, PMID 22985140, PMID 23175674, PMID 23682163, PMID 24055327, PMID 24705615, PMID 24933726, PMID 25603459, PMID 26385052, PMID 26511012, PMID 26829443, PMID 26982008, PMID 29052766, PMID 32046931, PMID 33210751, PMID 38682786
2005 (1)